Fermentation‐Driven Changes in Phenolic Compounds of Massa Medicata Fermentata
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Wei Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Liaoning, China. Hauptthemen laut MEDLINE: Phenols, Fermentation, Drugs, Chinese Herbal. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Bozhou Municipal Bureau of Science and Technology, National Natural Science Foundation of China, Foundation of Department of Education of Liaoning Province.
Abstract (Originalsprache)
Massa Medicata Fermentata (MMF), a clinically important fermented traditional Chinese medicine for treating gastrointestinal and metabolic disorders, struggles with quality control due to insufficient reliable reference materials. Because phenolic compounds are key ingredients of MMF, this study investigated how fermentation reshapes the phenolic profile of MMF and enhances its bioactivity. Using UPLC‐ESI‐MS/MS‐based metabolomics, we identified 119 phenolic compounds (PCs), 66 of which were previously unreported in MMF. Comparative analysis showed that fermentation significantly remodeled the PCs composition, notably enriching free phenolic acids, methoxylated flavonoids, and flavonoid C ‐glycosides compared to the unfermented precursor (BMMF). Consistent with these changes, MMF exhibited significantly stronger antioxidant and anti‐inflammatory activities than BMMF ( p < 0.01). Correlation analysis revealed strong correlations (∣ r ∣ > 0.8) between specific PCs and enhanced bioactivities. Our work not only clarifies the molecular basis for fermentation‐induced efficacy enhancement but also proposes evidence‐based phenolic markers to support the quality standardization of MMF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Liaoning, China.
- Jiren Pharmaceutical Group, Bozhou, Anhui, China.
ORCID-Profile: Nan Xu
Förderung
- Bozhou Municipal Bureau of Science and Technology
- National Natural Science Foundation of China
- Foundation of Department of Education of Liaoning Province
Zitieren
APA
Zheng, W., Li, J., Yin, L., Sun, J., Liu, L., Kong, B., Zhu, Y., & Xu, N. (2026). Fermentation‐Driven Changes in Phenolic Compounds of Massa Medicata Fermentata. Biomedical Chromatography. https://doi.org/10.1002/bmc.70394
Vancouver
Zheng W, Li J, Yin L, Sun J, Liu L, Kong B, et al. Fermentation‐Driven Changes in Phenolic Compounds of Massa Medicata Fermentata. Biomedical Chromatography. 2026. doi:10.1002/bmc.70394
BibTeX
@article{Zheng2026,
author = {Zheng, Wei and Li, Jiaqi and Yin, Lei and Sun, Jieying and Liu, Lu and Kong, Bing and Zhu, Yuexin and Xu, Nan},
title = {Fermentation‐Driven Changes in Phenolic Compounds of Massa Medicata Fermentata},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70394}
}
EUVIMED